Chang Ming-Che, Tsai Shih-Chuan, Lin Wan-Yu
Department of Nuclear Medicine, Changhua Christian Hospital, Changhua, Taiwan.
Kaohsiung J Med Sci. 2008 Oct;24(10):542-7. doi: 10.1016/S1607-551X(09)70014-2.
The possibility of a coincidental appearance of hyperparathyroidism and thyroid cancer is not often considered because of its low incidence. Here, we present a case of a 49-year-old woman with a parathyroid adenoma coexisting with two sites of papillary thyroid carcinoma. Dual-phase 99mTc-methoxyisobutylisonitrile (MIBI) parathyroid imaging before the operation correctly visualized the site of the parathyroid adenoma. In addition, two papillary thyroid carcinomas showed faint uptake of 99mTc-MIBI on delayed image. Total thyroidectomy and parathyroidectomy of a solitary parathyroid adenoma were performed. The patient subsequently underwent radioiodine-131 ablation and was treated with T4 suppression. This case illustrates the need for clinical awareness of concomitant hyperparathyroidism and thyroid cancer. Dual-phase 99mTc- MIBI parathyroid imaging may be useful for detecting indolent thyroid cancer before it becomes a distinct disease.
由于甲状旁腺功能亢进症与甲状腺癌同时出现的发生率较低,这种可能性并不常被考虑。在此,我们报告一例49岁女性病例,其甲状旁腺腺瘤与两个部位的甲状腺乳头状癌共存。术前双期99m锝-甲氧基异丁基异腈(MIBI)甲状旁腺显像正确显示了甲状旁腺腺瘤的位置。此外,两个甲状腺乳头状癌在延迟影像上显示出99mTc-MIBI的微弱摄取。对单个甲状旁腺腺瘤进行了甲状腺全切除术和甲状旁腺切除术。患者随后接受了碘-131消融治疗,并接受了T4抑制治疗。该病例表明临床需要认识到甲状旁腺功能亢进症与甲状腺癌的并存情况。双期99mTc-MIBI甲状旁腺显像可能有助于在惰性甲状腺癌发展为明显疾病之前进行检测。